Lupe, wouldn't worry about that, success in these trials would mean a staggering rerate. Besides, the options add considerable cash to the Company meaning less or no need for CR down the track. It is already factored in given they are in the money.
IHL Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held